|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 321.86 USD | -3.21% |
|
-0.72% | -36.37% |
| Nov. 14 | Soros Fund Management dissolves share stake in Coreweave | RE |
| Nov. 14 | Lone Pine Capital cuts share stake in Meta, Amazon, KKR, dissolves share stake in UnitedHealth | RE |
Evolution of the Average Target: UnitedHealth Group Inc.
Evolution of the Target Price: UnitedHealth Group Inc.
Changes in Analyst Recommendations: UnitedHealth Group Inc.
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +19.74% | |||||
| +18.5% | |||||
| +21.76% | |||||
| +21.65% | |||||
| +8.33% | |||||
| +25.44% | |||||
| +26.36% | |||||
| +17.22% | |||||
| +30.9% | |||||
| +40.9% | |||||
| Average | +23.08% | |||||
| Weighted average by Cap. | +19.71% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Morgan Stanley | |
| Bernstein | |
| TD Cowen | |
| UBS | |
| RBC Capital Markets | |
| Piper Sandler | |
| Oppenheimer | |
| Goldman Sachs | |
| Deutsche Bank Securities | |
| Jefferies & Co. | |
| Leerink Partners | |
| Mizuho Securities | |
| JPMorgan Chase | |
| Barclays | |
| KeyBanc Capital Markets | |
| Wells Fargo Securities | |
| HSBC | |
| Truist Securities | |
| BofA Securities | |
| Baird | |
| Wolfe Research | |
| Raymond James | |
| Nephron Research | |
| Argus | |
| Stephens Inc. | |
| Cantor Fitzgerald | |
| SVB Securities LLC | |
| Morningstar | |
| Loop Capital | |
| Credit Suisse | |
| BMO Capital | |
| SVB Leerink | |
| RBC | Ben Hendrix |
| Edward Jones | |
| Morgan Joseph | |
| Evercore ISI | |
| Citigroup | |
| Seaport Global Securities |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- UNH Stock
- Consensus UnitedHealth Group Inc.
Select your edition
All financial news and data tailored to specific country editions
